Gene · 4507
Papers2,281
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,281
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolic vulnerabilities in pleural mesothelioma. | Oncogenesis | 2026 | 42161911 | PubTator, text mining | PubMed |
| Case Report: The molecular profile of granular cell astrocytoma predicts aggressive clinical behavior, independent of morphology. | Pathol Oncol Res | 2026 | 42158566 | PubTator, text mining | PubMed |
| The Discovery of TNG456: A Highly Potent, Selective, Brain-Penetrant MTA-Cooperative PRMT5 Inhibitor for the Treatment of MTAP-Deleted Cancers. | J Med Chem | 2026 | 42150143 | PubTator, text mining | PubMed |
| Comprehensive Genomic and Transcriptomic Characterization of MTAP Loss across Advanced Solid Tumors. | Clin Cancer Res | 2026 | 42148883 | PubTator, text mining | PubMed |
| Impact of Chromosomal Instability and Aneuploidy in Cancer Development. | Annu Rev Cancer Biol | 2026 | 42137044 | PubTator, text mining | PubMed |
| Genomics of MTAP Loss in >500,000 Solid Tumor Specimens Profiled Using Comprehensive Genomic Profiling Platforms. | JCO Precis Oncol | 2026 | 42133901 | PubTator, text mining | PubMed |
| MTAP loss in gastrointestinal cancers is associated with CDKN2A deletion, poor prognosis in gastric carcinoma, and potential relevance for PRMT5-targeted therapy. | Sci Rep | 2026 | 42129334 | PubTator, text mining | PubMed |
| Inactivation of PRMT5 by PARP Inhibitors Confers High Susceptibility in MTAP-Deficient Cancers. | Cancers (Basel) | 2026 | 42122132 | PubTator, text mining | PubMed |
| Metastatic Meningioma with Systemic Involvement: Discussion of Molecular, Genomic, and Radiological Features. | World Neurosurg | 2026 | 42107879 | PubTator, text mining | PubMed |
| MTAP loss in gallbladder carcinoma: frequency, heterogeneity and expression in precursor lesions. | J Clin Pathol | 2026 | 42103452 | PubTator, text mining | PubMed |
| Targeting key epigenetic regulators in solid tumors: focus on EZH2, PRMT5, and BET inhibitors. | Cancer Treat Rev | 2026 | 42096787 | PubTator, text mining | PubMed |
| Emerging role of protein arginine methyltransferase 5 in gastrointestinal cancer (Review). | Oncol Lett | 2026 | 42094816 | PubTator, text mining | PubMed |
| Genetic analysis of primary lung interdigitating dendritic cell sarcomas. | J Pathol | 2026 | 42092301 | PubTator, text mining | PubMed |
| Adenomatoid Tumor of the Uterus With Marked Nuclear Atypia: A Case Report Including Next-Generation Sequencing Analysis and Review of the Literature. | Int J Surg Pathol | 2026 | 42084543 | PubTator, text mining | PubMed |
| Targeting purinergic signaling and MTAP-associated metabolism in cancer: A functional immunometabolic convergence framework. | Biochem Pharmacol | 2026 | 42082122 | PubTator, text mining | PubMed |
| Acquired resistance to the PRMT5 inhibitor confers collateral sensitivity to MEK inhibition in MTAP-null non-small cell lung cancer. | bioRxiv | 2026 | 42079286 | PubTator, text mining | PubMed |
| Isolated primary pericardial sarcomatoid mesothelioma: a case report. | Front Oncol | 2026 | 42052488 | PubTator, text mining | PubMed |
| Impact of Copy Number Alterations on Human Papillomavirus (HPV)-Induced and HPV-Independent Penile Cancers. | Lab Invest | 2026 | 42031074 | PubTator, text mining | PubMed |
| Design and Discovery of Pyridazinone-Based MAT2A Inhibitors Targeting MTAP-Deficient Cancers. | J Med Chem | 2026 | 42024642 | PubTator, text mining | PubMed |
| TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD-Deleted Cancers. | Cancer Discov | 2026 | 42001523 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4507/papers?page=5